# Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)

> **NCT00421538** · PHASE3 · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 260 (actual)

## Conditions studied

- Distal (Calf) Deep-vein Thrombosis

## Interventions

- **DRUG:** nadroparine calcium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00421538
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2015-05
- **Final completion:** 2015-08
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2018-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421538, "Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT00421538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*